Scientific principles in design of drug dosage formulations.
D000284:Administration, Oral; D000667:Ampicillin / Q000378:metabolism; D000818:Animals; D001241:Aspirin / Q000378:metabolism; D001463:Barbiturates / Q000378:metabolism; D002021:Buffers; D002214:Capsules; D003460:Crystallization; D004339:Drug Compounding; D004355:Drug Stability; D005753:Gastric Mucosa / Q000378:metabolism; D006118:Griseofulvin / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D008775:Methylprednisolone; D010118:Oxytetracycline / Q000097:blood; D012457:Salicylamides / Q000008:administration & dosage; D012996:Solutions; D013535:Suspensions; D013607:Tablets; D013810:Therapeutic Equivalency; D014044:Tolbutamide / Q000008:administration & dosage; D014867:Water
D001463:Barbiturates; D002021:Buffers; D002214:Capsules; D012457:Salicylamides; D012996:Solutions; D013535:Suspensions; D013607:Tablets; D014867:Water; D006118:Griseofulvin; D000667:Ampicillin; D014044:Tolbutamide; D001241:Aspirin; D010118:Oxytetracycline; D008775:Methylprednisolone